Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
7 (23%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-10-21 | 2023-04-01 | 147787 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80811 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147790 |
| MINT-METFORMIN | 500MG | TABLET | Actual shortage | 2019-02-04 | 2019-02-05 | 74455 |
| MINT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-04-12 | 2018-05-04 | 45542 |
| MINT-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122521 |
| MINT-OLANZAPINE | 5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122524 |
| MINT-OLANZAPINE | 10MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122527 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35467 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108295 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35470 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108298 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35473 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108301 |
| MINT-ONDANSETRON | 4MG | TABLET | Resolved | 2017-10-26 | 2018-03-10 | 27164 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2017-10-26 | 2017-11-22 | 27173 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2021-01-11 | 2021-03-23 | 131330 |
| MINT-OSELTAMIVIR | 75MG | CAPSULE | Actual shortage | 2022-01-05 | 2023-01-03 | 152092 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-04-06 | 2018-10-17 | 45121 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-04-06 | 2018-08-22 | 45124 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
| MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
| MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
| MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |